Abstract
Anthracyclines are effective in the treatment of leukemia, but their use is limited because of cardiotoxicity. Liposomal daunorubicin (L-DNR) is potentially less cardiotoxic than daunorubicin (DNR). We compared in vitro cytotoxicity in pediatric acute leukemia samples and found no significant differences between cytotoxicity of DNR and L-DNR.
Original language | English |
---|---|
Pages (from-to) | 1573-1574 |
Number of pages | 2 |
Journal | Haematologica |
Volume | 91 |
Issue number | 11 |
Publication status | Published - Nov 2006 |
Keywords
- Cardiotoxicity
- Drug sensitivity
- Liposomal daunombicin
- Pediatric acute leukemia